Ido Cohen serves as the Senior Director of Projects and Validation at Protalix BioTherapeutics, where he leverages over 25 years of extensive experience in project management, manufacturing, engineering, quality, and compliance within the biotech and pharmaceutical sectors. In his current role, Ido is instrumental in...
Ido Cohen serves as the Senior Director of Projects and Validation at Protalix BioTherapeutics, where he leverages over 25 years of extensive experience in project management, manufacturing, engineering, quality, and compliance within the biotech and pharmaceutical sectors. In his current role, Ido is instrumental in guiding cross-functional teams through the complex journey of new product development, from early discovery phases to clinical trials and eventual commercialization. His leadership is characterized by a strong emphasis on strategic partnerships, which are crucial for navigating the multifaceted landscape of biopharmaceutical innovation.
Ido’s expertise extends to spearheading business development and licensing (BD&L) initiatives, as well as mergers and acquisitions (M&A). He leads due diligence teams to meticulously evaluate potential assets and collaborations, ensuring alignment with Protalix’s strategic vision and market positioning. His strategic insights are pivotal in identifying opportunities that enhance the company’s portfolio and drive growth.
In addition to his leadership in project management, Ido directs comprehensive project lifecycles, ensuring that all processes adhere to stringent industry standards and regulatory compliance. His proficiency in Good Manufacturing Practices (GMP), quality management, and regulatory affairs positions him as a key player in maintaining the highest quality standards throughout the product development pipeline. Ido’s ability to foster collaboration among multidisciplinary teams not only enhances operational efficiency but also accelerates the path to market for innovative therapies, ultimately contributing to Protalix's mission of delivering transformative treatments to patients in need.
